Comparison of the Biomechanical Properties of the Wall of an Aneurysmal-altered Abdominal Aorta According to the Results of in Vivo Ultrasound and an Associated Study of Strength Characteristics in Vitro
Prospective Assessment of the Biomechanical Properties of the Wall of an Aneurysmal-altered Abdominal Aorta According to the Results of in Vivo Ultrasound and an Associated Study of Strength Characteristics in Vitro
1 other identifier
observational
50
1 country
3
Brief Summary
Identification of the regression model between the strength properties of tissue and its ultrasonic spectral characteristics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2023
Shorter than P25 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 21, 2022
CompletedFirst Posted
Study publicly available on registry
December 1, 2022
CompletedStudy Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2023
CompletedDecember 14, 2022
November 1, 2022
29 days
November 21, 2022
December 13, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Calculate the relationship between the strength properties of the tissue and its ultrasonic spectral characteristics
Identification of the regression relationship between the elasto-elastic and strength properties of the tissue and its ultrasonic characteristics will make it possible to determine the most significant diagnostic ultrasonic criteria for aortic wall deformation, which determine the increased risk of its rupture and thromboembolic complications in a particular patient.
1 year
Secondary Outcomes (3)
Measurement of elastic-elastic properties of the aortic wall using ultrasonic speckle tracking
at least one day prior to surgery
Measurement of the strength properties of the aneurysm wall in uniaxial tension in vitro
1 month
Measure linearity limits as well as shear yield strength in vitro
1 month
Interventions
Patients with aneurysms of the abdominal aorta undergo an ultrasound examination of the abdominal aorta to assess the elastic properties of the aortic wall. The accessible wall of the abdominal aortic aneurysm is taken intraoperatively. In in vitro studies, the strength properties of the aneurysm wall are measured during uniaxial tension on a tensile testing machine, which makes it possible to evaluate the elastic properties of the test sample. The assessment of the boundaries of the linearity of the surface under study, as well as the yield strength of the vascular wall and thrombotic masses, is evaluated under shear stresses using a rheometer. To correlate the mechanical properties with the structural composition of the aneurysm tissue, spectral analysis of the studied tissues by laser-induced fluorescence and histological examination with staining of the obtained sections for the presence of elastic fibers, fibrous tissues and calcification will be used.
Eligibility Criteria
Male and female patients aged 45 to 75 with a diagnosed aneurysmal dilatation of the abdominal aorta requiring its surgical correction, recruited in accordance with the inclusion/exclusion criteria
You may qualify if:
- Patients with an aneurysmal expansion of the abdominal aorta who are indicated for surgery.
- Patients who consented to participate in this study
You may not qualify if:
- Chronic heart failure III-IV functional class according to the NYHA classification;
- Chronic decompensated "pulmonary" heart;
- Severe hepatic or renal insufficiency (bilirubin \> 35 mmol / l, glomerular filtration rate \< 60 ml / min);
- Polyvalent drug allergy;
- Malignant oncological diseases in the terminal stage with a predicted lifespan of up to 6 months;
- Acute violation of cerebral circulation;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Alexander A Gostev
Novosibirsk, Novosibirskaya Obl, 630005, Russia
Federal State Institution Academician E.N.Meshalkin Novosibirsk State Research Institute Of Circulation Pathology Rusmedtechnology
Novosibirsk, 630055, Russia
E. Meshalkin National Medical Research Center
Novosibirsk, Russia
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Month
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 21, 2022
First Posted
December 1, 2022
Study Start
January 1, 2023
Primary Completion
January 30, 2023
Study Completion
April 30, 2023
Last Updated
December 14, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Access to data after first publication at the request of researchers
- Access Criteria
- on personal request
Access to data after first publication at the request of researchers